Fibrostenotic Phenotype of Myofibroblasts in Crohn's Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition

MLA

Geert R. D’Haens, et al. “Fibrostenotic Phenotype of Myofibroblasts in Crohn’s Disease Is Dependent on Tissue Stiffness and Reversed by LOX Inhibition.” Journal of Crohn’scolitis, vol. 12, no. 7, Nov. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f8c60d8f27d7cc91aad5109d69ee241&authtype=sso&custid=ns315887.

APA

Geert R. D’Haens, Gijs R. van den Brink, Jessica Steenkamer, Anje A. te Velde, Jessica R. de Bruyn, Willem A. Bemelman, Manon E. Wildenberg, Vanesa Muncan, Sander Meisner, & Christianne J. Buskens. (2017). Fibrostenotic Phenotype of Myofibroblasts in Crohn’s Disease is Dependent on Tissue Stiffness and Reversed by LOX Inhibition. Journal of Crohn’scolitis, 12(7).

Chicago

Geert R. D’Haens, Gijs R. van den Brink, Jessica Steenkamer, Anje A. te Velde, Jessica R. de Bruyn, Willem A. Bemelman, Manon E. Wildenberg, Vanesa Muncan, Sander Meisner, and Christianne J. Buskens. 2017. “Fibrostenotic Phenotype of Myofibroblasts in Crohn’s Disease Is Dependent on Tissue Stiffness and Reversed by LOX Inhibition.” Journal of Crohn’scolitis 12 (7). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4f8c60d8f27d7cc91aad5109d69ee241&authtype=sso&custid=ns315887.